OST1 Antibody

What is OST1 and why are antibodies against it important in plant research?

OST1 (Open Stomata 1) is a serine/threonine protein kinase that serves as a positive regulator in ABA-mediated stomatal responses in Arabidopsis. It plays a limiting role in ABA signaling pathways, interacting with ion channels and other proteins to regulate stomatal closure and opening .

Antibodies against OST1 are critical tools in plant molecular biology because they allow researchers to:

• Detect and quantify OST1 protein levels in different tissues or under various conditions

• Immunoprecipitate OST1 to study its interactions with other proteins

• Examine OST1 localization within cells via immunofluorescence

• Validate the specificity of genetic manipulations (knockout or overexpression)

• Study post-translational modifications of OST1, particularly phosphorylation events

These applications are essential for understanding OST1's role in ABA signaling, drought responses, and stomatal regulation, which have significant implications for crop improvement and climate resilience research.

How can I validate the specificity of an OST1 antibody?

Validating the specificity of an OST1 antibody is crucial to ensure reliable experimental results. A comprehensive validation approach should include:

• Genetic controls: Test the antibody in wild-type plants alongside ost1 loss-of-function mutants. A specific antibody should show a band at the expected molecular weight in wild-type samples but not in the mutant .

• Overexpression controls: Compare signal intensity between wild-type plants and transgenic lines overexpressing OST1 (such as OST1-myc or OST1-YFP). A specific antibody should detect stronger signals in overexpression lines .

• Peptide competition assay: Pre-incubate the antibody with the peptide used for immunization before applying to samples. This should diminish or eliminate specific signals.

• Cross-reactivity assessment: Test the antibody against recombinant OST1 protein expressed in E. coli, as well as related kinases from the SnRK2 family to verify specificity.

• Immunoprecipitation validation: Perform immunoprecipitation followed by mass spectrometry to confirm that the enriched protein is indeed OST1 and not a cross-reactive protein.

The use of both ost1 mutants and OST1-overexpressing lines as described in the literature provides robust positive and negative controls for antibody validation .

What are the recommended fixation and extraction protocols for OST1 detection in plant tissues?

For optimal OST1 detection in plant tissues, consider the following protocols:

Protein Extraction Protocol:

• Harvest fresh plant material (preferably guard cell-enriched epidermal peels for stomatal studies).

• Immediately flash-freeze in liquid nitrogen.

• Grind tissue to a fine powder while maintaining freezing conditions.

• Extract proteins in buffer containing:

  • 50 mM Tris-HCl, pH 7.5

  • 150 mM NaCl

  • 0.5% Nonidet P-40 or Triton X-100

  • 1 mM EDTA

  • 1 mM DTT

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (crucial for preserving phosphorylation status)

• Centrifuge at 14,000 × g for 15 minutes at 4°C.

• Collect supernatant for further analysis.

Tissue Fixation for Immunolocalization:

• Fix tissues in 4% paraformaldehyde in PBS for 1-2 hours.

• Wash with PBS buffer.

• For enhanced penetration in leaf tissues, consider additional permeabilization with 0.1% Triton X-100.

• Proceed with standard immunohistochemistry protocols.

These protocols are particularly important when studying OST1's dynamic localization and activation in response to ABA and brassinosteroid treatments .

How can I use OST1 antibodies to study phosphorylation-dependent activation?

OST1 activity is regulated through phosphorylation events that can be effectively studied using phospho-specific antibodies and general OST1 antibodies. A comprehensive approach includes:

• In-gel kinase assays: Immunoprecipitate OST1 using anti-OST1 antibodies from plants treated with ABA or brassinosteroids, then assess kinase activity in gel using appropriate substrates like myelin basic protein (MyBP). This approach has been used to demonstrate that brassinolide (BL) activates OST1 in a CDL1-dependent manner .

• Phospho-specific antibody detection: Generate or obtain antibodies that specifically recognize phosphorylated residues of OST1, particularly the activation loop phosphorylation sites. Western blotting with these antibodies can directly measure OST1 activation state.

• Transphosphorylation analysis: To study interactions such as the CDL1-OST1 transphosphorylation:

  • Immunoprecipitate OST1-myc from transgenic plants

  • Perform kinase assays with substrates like MyBP

  • Compare activities between wild-type and mutant lines (such as cdl1)

  • Monitor how treatments (ABA, BL) affect OST1 kinase activity

• Mass spectrometry validation: After immunoprecipitation with OST1 antibodies, perform mass spectrometry to identify specific phosphorylation sites and quantify their relative abundance after different treatments.

Research has shown that ABA and brassinosteroid treatments increase OST1 activity through different mechanisms, with Ser-7 of OST1 being a critical residue for phosphorylation by CDL1 .

What are the best protocols for studying OST1 protein-protein interactions using co-immunoprecipitation?

For robust co-immunoprecipitation (co-IP) studies of OST1 interactions with partners like KAT1, SLAC1, and NADPH oxidases, follow these methodological guidelines:

Co-IP Protocol for OST1 Interactions:

• Sample preparation:

  • Harvest and flash-freeze 2-3g of leaf tissue from plants expressing tagged OST1 (e.g., OST1-myc) or use anti-OST1 antibodies for endogenous protein

  • Grind tissue in liquid nitrogen to fine powder

  • Extract proteins in buffer containing:

    • 50 mM Tris-Cl, pH 7.5

    • 150 mM NaCl

    • 0.2% Nonidet P-40

    • Protease inhibitor cocktail

    • Phosphatase inhibitors

  • Centrifuge at 14,000 × g for 15 min at 4°C

  • Collect supernatant and determine protein concentration

• Pre-clearing:

  • Incubate extract with protein A/G beads for 1 hour at 4°C

  • Remove beads by centrifugation

• Immunoprecipitation:

  • Add anti-myc antibody (for OST1-myc) or anti-OST1 antibody to pre-cleared extract

  • Incubate 2-3 hours or overnight at 4°C with gentle rotation

  • Add protein A/G beads and incubate additional 1-2 hours

  • Wash beads 3-5 times with wash buffer (similar to extraction buffer but with reduced detergent)

• Elution and analysis:

  • Elute proteins with 2× SDS sample buffer

  • Analyze by SDS-PAGE and immunoblotting using antibodies against suspected interaction partners

This protocol has been successfully used to demonstrate that CDL1-YFP co-immunoprecipitates with OST1-myc, and that this interaction is enhanced by both ABA and brassinosteroid treatments . Additionally, studies have confirmed physical interactions between OST1 and the inward K+ channel KAT1, the anion channel SLAC1, and NADPH oxidases AtrbohD and AtrbohF .

How can OST1 antibodies be utilized in chromatin immunoprecipitation (ChIP) studies?

While OST1 itself is not a transcription factor, it regulates transcription factors through phosphorylation, such as ABF3 . Studying these interactions through ChIP requires a modified approach:

ChIP Protocol for OST1-Regulated Transcription Factors:

• Sequential ChIP (ChIP-reChIP) approach:

  • First, perform ChIP with antibodies against the transcription factor (e.g., anti-ABF3)

  • Elute the complexes under non-denaturing conditions

  • Perform a second round of ChIP using anti-OST1 antibodies

  • This identifies genomic regions where both the transcription factor and OST1 are present

• Proximity ligation assay (PLA) combined with ChIP:

  • Cross-link proteins to DNA using formaldehyde (1-1.5%, 10-15 minutes)

  • Perform PLA using anti-OST1 and anti-transcription factor antibodies

  • Proceed with standard ChIP protocol using PLA signal amplification

  • This detects specific genomic regions where OST1 is in close proximity to transcription factors

• ChIP for phosphorylated transcription factors:

  • Generate phospho-specific antibodies against OST1-phosphorylated residues on transcription factors (e.g., ABF3 T451)

  • Perform ChIP using these antibodies

  • This identifies genomic regions bound by transcription factors phosphorylated by OST1

Research has demonstrated that OST1 phosphorylates ABF3 on T451 to create a 14-3-3 binding motif , suggesting that phosphorylation-dependent regulation of transcription factor activity is a key mechanism by which OST1 influences gene expression.

What are the technical considerations for using OST1 antibodies in FRET-FLIM studies?

Förster Resonance Energy Transfer coupled with Fluorescence Lifetime Imaging Microscopy (FRET-FLIM) can provide valuable spatial and temporal information about OST1 interactions in living cells. When using OST1 antibodies in such studies:

• Antibody modification for live-cell imaging:

  • Directly conjugate fluorophores (such as Alexa 488 or Cy3) to purified OST1 antibodies

  • Verify that conjugation doesn't affect antibody specificity

  • Consider using Fab fragments to reduce steric hindrance

• Protein delivery methods:

  • Microinjection of labeled antibodies into guard cells

  • Biolistic delivery of antibody-encoding constructs

  • Cell-penetrating peptide conjugation for antibody delivery

• FRET pairs selection:

  • For studying OST1-CDL1 interactions: Use OST1 antibodies labeled with donor fluorophores and CDL1 antibodies with acceptor fluorophores

  • Ensure spectral separation is appropriate for FRET measurements

  • Consider using genetically encoded fluorescent tags as alternatives (e.g., OST1-GFP and CDL1-mCherry)

• Controls and validation:

  • Negative controls: Non-interacting proteins with the same fluorophores

  • Positive controls: Known interacting proteins

  • Acceptor photobleaching to confirm FRET

  • Competition with unlabeled antibodies to verify specificity

• Physiological relevance:

  • Combine with treatments that activate OST1 (ABA, brassinosteroids)

  • Monitor dynamic changes in interaction upon stress induction

  • Correlate with functional outputs like stomatal aperture measurements

FRET-FLIM studies can help visualize the enhancement of OST1-CDL1 interaction that occurs upon treatment with both ABA and brassinosteroids, providing spatial information about where in the cell these interactions occur .

What are common challenges with OST1 detection in Western blots and how can they be overcome?

Researchers often encounter several challenges when detecting OST1 in Western blots. Here are common issues and their solutions:

• Weak or absent signal:

  • Solution: Optimize protein extraction by using buffers containing phosphatase inhibitors to preserve phosphorylated forms of OST1. Increase antibody concentration or incubation time. Consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity.

  • Rationale: OST1 is a low-abundance protein whose detection can be challenging; phosphorylation status affects antibody recognition.

• Multiple bands or non-specific binding:

  • Solution: Increase blocking time (5% BSA or milk, 1-2 hours), optimize antibody dilution, include 0.05-0.1% Tween-20 in wash buffers, and consider longer/more frequent washes.

  • Validation: Compare with OST1-overexpressing lines and ost1 mutants to identify the specific band .

• Variable results between experiments:

  • Solution: Standardize the physiological state of plants by precisely controlling growth conditions and treatment timing. For ABA or brassinosteroid treatments, use consistent concentrations and durations.

  • Context: OST1 activity and abundance change dramatically in response to environmental stimuli and hormone treatments .

• Difficulty detecting phosphorylated forms:

  • Solution: Use Phos-tag™ SDS-PAGE to separate phosphorylated from non-phosphorylated OST1 forms. Consider generating phospho-specific antibodies against key sites like Ser-7.

  • Evidence: Phosphorylation at Ser-7 by CDL1 is critical for OST1 activation .

• Post-extraction modifications:

  • Solution: Add phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) to all buffers. Maintain samples at 4°C and process quickly.

  • Importance: The phosphorylation status of OST1 is crucial for its function and may affect antibody recognition .

How can I optimize immunoprecipitation of OST1 for kinase activity assays?

Optimal immunoprecipitation (IP) of OST1 for subsequent kinase activity assays requires careful attention to preserve both protein interactions and enzymatic activity:

• Buffer optimization:

  • Use gentle, non-denaturing extraction buffer:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 0.1-0.2% Nonidet P-40 (avoid stronger detergents)

    • 1 mM EDTA

    • 1 mM DTT (to maintain kinase active site)

    • Protease inhibitor cocktail

    • Phosphatase inhibitors (critical for maintaining activation state)

• Antibody selection and coupling:

  • For tagged OST1: Use high-affinity anti-tag antibodies (anti-myc for OST1-myc)

  • For native OST1: Use affinity-purified OST1 antibodies

  • Consider covalently coupling antibodies to beads (using dimethyl pimelimidate) to prevent antibody contamination in kinase assays

• Washing conditions:

  • Balance between removing non-specific binding and preserving activity

  • Use 3-4 gentle washes with buffer containing reduced detergent (0.05% Nonidet P-40)

  • Include ATP (50-100 μM) in wash buffers to stabilize kinase-substrate interactions

• Elution strategies:

  • For in-gel kinase assays: Elute with SDS sample buffer

  • For solution kinase assays: Consider native elution using excess peptide (if peptide antibody was used) or use the beads directly in the kinase reaction

• Activity preservation controls:

  • Include positive controls from plants treated with ABA, which activates OST1

  • Compare activity between wild-type and OST1-overexpressing plants

  • Consider including 10% glycerol in all buffers as a protein stabilizer

These optimizations have been successfully employed in studies demonstrating that BL treatment increases OST1 activity in wild-type plants but not in cdl1 mutants, providing evidence for CDL1-dependent activation of OST1 by brassinosteroids .

What methodological approaches can resolve contradictory results in OST1 phosphorylation studies?

When faced with contradictory results regarding OST1 phosphorylation patterns or kinase activities, consider these methodological approaches:

• Comprehensive phosphorylation site mapping:

  • Perform mass spectrometry analysis of immunoprecipitated OST1 to identify all phosphorylation sites

  • Compare phosphorylation patterns from plants exposed to different stimuli (ABA vs. brassinosteroids)

  • Create phosphomimetic (S/T→D/E) and phospho-null (S/T→A) mutants for functional testing

  • Example: Studies have identified Ser-7 as a critical phosphorylation site for OST1 activation by CDL1

• Kinase assay standardization:

  • Use multiple substrates (MyBP, histone, and specific peptides) to compare kinase activities

  • Employ both in-gel and solution-based kinase assays

  • Include time-course studies to distinguish between fast and slow phosphorylation events

  • Standardize protein amounts through careful quantification methods

• Genetic complementation tests:

  • Express phospho-site mutants of OST1 in ost1 background

  • Compare physiological responses (stomatal closure) to hormones

  • Example: OST1 S7A-YFP failed to fully rescue ABA insensitivity of the ost1 mutant, confirming the importance of this phosphorylation site

• Pathway dissection through multiple mutants:

  • Analyze OST1 phosphorylation in various genetic backgrounds (cdl1, bak1, etc.)

  • Create and test double mutants to understand pathway crosstalk

  • Example: OST1 activation by brassinosteroids was abolished in the cdl1 mutant, indicating CDL1-dependent regulation

• Temporal resolution of signaling events:

  • Perform time-course experiments with precise sampling

  • Use rapid treatment methods with immediate tissue fixation

  • Quantify changes in phosphorylation at specific sites over time

  • Correlate molecular changes with physiological responses

This systematic approach has helped resolve apparent contradictions in OST1 regulation, revealing that both ABA and brassinosteroids can activate OST1 through different mechanisms, with transphosphorylation between OST1 and CDL1 mediating crosstalk between these hormonal pathways .

How can OST1 antibodies be used to investigate stomatal regulation in non-model plants?

Extending OST1 research to non-model plants requires careful antibody selection and experimental design:

• Cross-species antibody validation:

  • Perform sequence alignment of OST1 orthologs across species of interest

  • Design or select antibodies against highly conserved regions

  • Validate antibody cross-reactivity using recombinant proteins from different species

  • Test antibody specificity in each new species using RNAi or CRISPR knockout lines where possible

• Comparative stomatal physiology studies:

  • Use immunolocalization to compare OST1 distribution in guard cells across species

  • Correlate OST1 activity (through phosphorylation-specific antibodies) with stomatal responses to drought, ABA, and other stimuli

  • Compare kinase activity of immunoprecipitated OST1 from different species under standardized conditions

• Adaptation to different tissue types:

  • Modify protein extraction protocols based on tissue composition (e.g., higher detergent for waxy leaves)

  • Develop tissue-specific isolation procedures for guard cell-enriched samples

  • Optimize immunoprecipitation conditions for different cellular environments

• Evolutionary conservation assessment:

  • Compare OST1-interacting partners across species using co-immunoprecipitation

  • Determine if the interactions with key proteins (KAT1, SLAC1, NADPH oxidases) are conserved

  • Investigate whether the transphosphorylation between OST1 and CDL1 occurs in diverse plant lineages

This approach can reveal how OST1 function in stomatal regulation has evolved across plant taxa and identify conserved mechanisms that might be targeted for crop improvement strategies.

What are the best methods for quantifying OST1 phosphorylation at specific residues?

Precise quantification of OST1 phosphorylation at specific residues requires a combination of techniques:

• Phospho-specific antibody approaches:

  • Generate antibodies against phosphopeptides containing key sites (e.g., phospho-Ser-7)

  • Validate specificity using phospho-null mutants (S7A) and dephosphorylated samples

  • Employ quantitative immunoblotting with fluorescent secondary antibodies

  • Use dot blot arrays for high-throughput screening of multiple samples

• Mass spectrometry-based quantification:

  • Targeted approaches:

    • Selected reaction monitoring (SRM) for specific phosphopeptides

    • Parallel reaction monitoring (PRM) for improved selectivity

  • Enrichment strategies:

    • Titanium dioxide (TiO2) or immobilized metal affinity chromatography (IMAC)

    • Phospho-specific antibody enrichment prior to MS analysis

  • Quantification methods:

    • Label-free quantification based on precursor intensity

    • Stable isotope labeling (SILAC, TMT, iTRAQ) for precise relative quantification

• Phos-tag™ gel electrophoresis:

  • Separates phosphorylated from non-phosphorylated OST1 forms

  • Can distinguish multiple phosphorylation states

  • Combine with western blotting using total OST1 antibodies

  • Analyze band intensity ratios to determine relative phosphorylation levels

• In-cell validation of phosphorylation events:

  • Express phospho-reporter constructs in guard cells

  • Use FRET-based reporters designed around OST1 phosphorylation sites

  • Correlate phosphorylation dynamics with stomatal responses

Research has shown that phosphorylation of OST1 at Ser-7 by CDL1 is critical for its activation, and mutating this residue to alanine (S7A) reduces the responsiveness to both ABA and brassinosteroids in stomatal closure assays . Quantifying these phosphorylation events is essential for understanding the molecular mechanisms of hormone crosstalk in guard cells.

How can OST1 antibodies be employed in single-cell proteomics of guard cells?

Single-cell proteomics of guard cells represents a frontier in understanding stomatal regulation at the cellular level. OST1 antibodies can be pivotal in this approach:

• Guard cell isolation and verification:

  • Develop protocols for isolating individual guard cells or guard cell pairs

  • Verify cell identity using guard cell-specific markers

  • Use immunofluorescence with anti-OST1 antibodies to confirm guard cell identity, as OST1 is predominantly expressed in guard cells

• Proximity labeling proteomics:

  • Express OST1 fused to proximity labeling enzymes (BioID, TurboID, APEX2)

  • Activate labeling during specific treatments (ABA, drought, BR)

  • Purify biotinylated proteins using streptavidin

  • Identify OST1 interactors specific to different conditions

  • Validate key interactions using co-immunoprecipitation with OST1 antibodies

• Single-cell immunoprecipitation:

  • Miniaturize IP protocols for microscale samples

  • Use microfluidic devices for processing individual isolated guard cells

  • Employ OST1 antibodies coupled to magnetic nanoparticles

  • Combine with highly sensitive mass spectrometry

• In situ protein interaction analysis:

  • Apply proximity ligation assay (PLA) to tissue sections

  • Use OST1 antibodies paired with antibodies against suspected interaction partners

  • Quantify interaction signals at the single-cell level

  • Compare interaction profiles across different stimuli and genotypes

• Correlation with single-cell transcriptomics:

  • Integrate proteomics data with single-cell RNA-seq from guard cells

  • Correlate OST1 protein levels/modifications with transcript dynamics

  • Identify regulatory feedback mechanisms

This integrated approach can reveal how OST1 functions specifically in guard cells and how its interactions change during stomatal responses to environmental stimuli, providing a more complete understanding of OST1's critical role in ABA and brassinosteroid signaling convergence in stomatal regulation .

How can multicolor super-resolution microscopy be optimized for OST1 localization studies?

Super-resolution microscopy offers unprecedented insights into OST1 subcellular localization and dynamic redistribution during signaling events:

• Antibody conjugation strategies for multicolor imaging:

  • Directly label OST1 antibodies with photo-switchable fluorophores (Alexa 647, Atto 488, Cy3B)

  • Use secondary antibodies labeled with distinct fluorophores for multiplexing

  • Consider quantum dots for long-term imaging with reduced photobleaching

  • Validate that labeling doesn't affect antibody specificity or sensitivity

• Sample preparation optimization:

  • Use thin tissue sections (5-10 μm) or isolated epidermal peels

  • Apply chemical fixation protocols optimized for structure preservation:

    • 4% paraformaldehyde with 0.05-0.1% glutaraldehyde

    • Low concentration of Triton X-100 (0.01-0.05%) for controlled permeabilization

  • Consider hydrogel embedding for expansion microscopy

• OST1 co-localization targets:

  • Pair OST1 antibodies with markers for different subcellular compartments:

    • Plasma membrane markers to study membrane association during activation

    • Nuclear markers to investigate potential nuclear translocation

    • SLAC1 and KAT1 to visualize co-localization with ion channels

    • CDL1 to study interaction sites during hormone responses

• Technical considerations for plant tissues:

  • Address autofluorescence using spectral unmixing or specialized imaging buffers

  • Optimize imaging buffers containing oxygen scavenging systems

  • Use confocal spinning disk systems for reduced photobleaching

  • Consider light-sheet microscopy for reduced phototoxicity in live-cell imaging

• Dynamic studies:

  • Develop protocols for rapid fixation at different time points after ABA or BR treatment

  • Track OST1 redistribution in response to environmental stimuli

  • Correlate with functional responses like calcium signaling or ROS production

These approaches can reveal how OST1 dynamically interacts with its substrates and regulatory partners at the nanoscale level, providing new insights into the spatial organization of ABA and brassinosteroid signaling in guard cells.

What are the current challenges in developing conformation-specific OST1 antibodies?

Developing antibodies that specifically recognize different conformational states of OST1 presents several challenges but offers tremendous potential for studying activation mechanisms:

• Conformational state stabilization:

  • Active conformation: Generate antibodies against OST1 co-crystallized with ATP or ATP analogs

  • Inactive conformation: Develop antibodies against OST1 in complex with inhibitory domains or proteins

  • Phosphorylated state: Specifically target the activation loop in its phosphorylated form

  • Challenge: Maintaining these conformations during antibody production and screening

• Epitope design considerations:

  • Target regions that undergo significant conformational changes upon activation

  • Focus on the activation loop and catalytic site

  • Consider regions involved in protein-protein interactions with substrates like SLAC1 or KAT1

  • Ser-7 region, which is critical for CDL1-mediated phosphorylation

• Validation strategies:

  • Structural validation: Compare antibody binding to active versus inactive OST1 structures

  • Functional correlation: Verify that antibody binding correlates with measured kinase activity

  • Mutant analysis: Test against OST1 conformational mutants with altered activity

  • Phosphorylation state: Confirm specificity using phospho-null (S7A) and phosphomimetic mutations

• Application protocols:

  • Develop non-denaturing immunoprecipitation protocols

  • Optimize native gel electrophoresis for maintaining conformations

  • Establish flow cytometry protocols for quantifying conformational states

  • Design intracellular antibody expression systems (intrabodies) for live-cell imaging

Conformation-specific antibodies could reveal how OST1 activation states change during responses to different stimuli, particularly addressing whether ABA and brassinosteroids induce distinct conformational changes despite both activating OST1 kinase activity .

How can OST1 antibodies be utilized in plant synthetic biology applications?

OST1 antibodies can be valuable tools in plant synthetic biology, enabling novel approaches to engineering stomatal responses:

• Engineered synthetic circuits for drought resilience:

  • Create OST1-based biosensors using:

    • Split-antibody complementation systems

    • Nanobodies derived from OST1 antibodies fused to reporters

    • FRET-based reporters using OST1 antibody fragments

  • Monitor OST1 activation states in real-time as an early drought response indicator

• Controlled proteolysis applications:

  • Develop antibody-based degrons targeting OST1

  • Create conditional OST1 regulation systems:

    • Auxin-inducible degradation with anti-OST1 nanobodies

    • Light-controlled activation/inactivation of OST1 signaling

  • Fine-tune stomatal responses by precisely modulating OST1 levels

• Scaffold-based signaling engineering:

  • Create synthetic scaffolds using OST1 antibodies or fragments

  • Co-localize OST1 with its substrates (SLAC1, KAT1) to enhance signaling efficiency

  • Design orthogonal signaling pathways by controlling OST1 substrate proximity

• Multi-crop validation methods:

  • Develop antibody-based diagnostic tools to assess OST1 activity across species

  • Create standardized assays for evaluating engineered OST1 variants in diverse plants

  • Design quantitative immunoassays for high-throughput phenotyping of OST1 function

• Multiplexed modification detection:

  • Deploy antibody arrays for detecting multiple OST1 post-translational modifications

  • Monitor OST1 cross-regulation by different signaling pathways (ABA and BR)

  • Track signal integration at the OST1 node in engineered signaling networks

These synthetic biology applications could lead to crops with enhanced water-use efficiency by fine-tuning OST1-dependent stomatal responses, leveraging the understanding of OST1's role as a limiting factor in ABA responses and its regulation through phosphorylation at specific residues .